https://nsc9221inhibitor.com/e....xactly-why-are-video
Second, the study will assess the preliminary efficacy of ABM + tDCS in reducing being hungry in people who take antipsychotic medication. TECHNIQUES Thirty adults with a DSM-V diagnosis of schizophrenia or schizoaffective condition treated with anti-psychotic medication is likely to be arbitrarily assigned to receive five sessions that will combine ABM and real or sham tDCS, in a parallel group design. In this feasibility studced weight gain. TEST REGISTRATION ISRCTN Registry, ISRCTN13280178.
Like
Comment
Share
